A clear guide to GLP-1 receptor agonists, the class of medications behind Ozempic, Wegovy, and more. Learn what they are, how they work in the body, and how the different options compare for diabetes and weight loss.
GLP-1 Agonists
Erectile dysfunction affects millions of men, and many share overlapping risk factors with obesity and type 2 diabetes. Emerging research suggests GLP-1 medications like semaglutide may improve sexual health alongside metabolic health. Here is what the current evidence shows and what questions to bring to your doctor.
New obesity treatment guidance is pushing for dietitian-led care to work alongside GLP-1 medications like semaglutide and tirzepatide. If you're on or considering a GLP-1 drug, this shift could change how your care is structured and what to ask your provider. Here's what patients need to know.
Oral semaglutide prescriptions for Wegovy dropped for the first time, raising questions about patient preferences, cost, and effectiveness compared to injectable GLP-1s. If you're weighing your options, here's what this trend actually tells you and what questions to bring to your doctor.
Dosing errors with GLP-1 medications like semaglutide and tirzepatide are drawing increased attention from medical experts. Whether you're on a branded drug or a compounded version, getting the dose right is critical for both safety and results. Here's what you need to know to protect yourself.
Prescriptions for the oral Wegovy pill declined for the first time, raising questions about patient preferences and the real-world performance of oral GLP-1 medications. Here is what the data means for anyone weighing injectable versus pill-form options and how to make the best choice for your situation.
GLP-1 medications help millions lose weight, but some patients and researchers are asking whether that weight loss comes at the cost of muscle strength. A new study out of St. Louis is investigating this question directly. Here's what current evidence shows and what you can do about it right now.
Stopping GLP-1 medications often leads to weight regain, but a new study from Dartmouth suggests an outpatient endoscopic procedure could help patients maintain their results. This article breaks down how it works, who might benefit, and what questions to ask your doctor before pursuing this option.
Novo Nordisk has released positive early response data from its oral semaglutide 25mg trial, the pill version of Wegovy. Here's what the findings mean for patients currently on injectable GLP-1s and those who have been waiting for a needle-free option.
.avif)
